{"id":"https://openalex.org/W7167468614","doi":"https://doi.org/10.1186/s12981-026-00921-1","title":"Lenacapavir: a transformative advance in HIV therapy and prevention\u2014promise, access, and equity in Africa","display_name":"Lenacapavir: a transformative advance in HIV therapy and prevention\u2014promise, access, and equity in Africa","publication_year":2026,"publication_date":"2026-07-06","ids":{"openalex":"https://openalex.org/W7167468614","doi":"https://doi.org/10.1186/s12981-026-00921-1","pmid":"https://pubmed.ncbi.nlm.nih.gov/42410439"},"language":"en","primary_location":{"id":"doi:10.1186/s12981-026-00921-1","doi":"https://doi.org/10.1186/s12981-026-00921-1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-026-00921-1","pdf_url":null,"source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7167468614"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s12981-026-00921-1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091524870","display_name":"Stephen Olaide Aremu","orcid":"https://orcid.org/0000-0002-7473-7254","observed_orcids":["https://orcid.org/0000-0002-7473-7254"]},"institutions":[{"id":"https://openalex.org/I31959934","display_name":"Nasarawa State University","ror":"https://ror.org/04ybvje46","country_code":"NG","type":"education","lineage":["https://openalex.org/I31959934"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Stephen Olaide Aremu","raw_affiliation_strings":["Global Health and Infectious Diseases and Control Institute, Nasarawa State University, Keffi, Nasarawa State, Nigeria"],"raw_orcid":"https://orcid.org/0000-0002-7473-7254","affiliations":[{"raw_affiliation_string":"Global Health and Infectious Diseases and Control Institute, Nasarawa State University, Keffi, Nasarawa State, Nigeria","institution_ids":["https://openalex.org/I31959934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116502338","display_name":"Deborah Bukola Aremu","orcid":"https://orcid.org/0009-0006-2292-4329","observed_orcids":["https://orcid.org/0009-0006-2292-4329"]},"institutions":[{"id":"https://openalex.org/I76661892","display_name":"Federal University of Technology Minna","ror":"https://ror.org/0568y3j03","country_code":"NG","type":"education","lineage":["https://openalex.org/I76661892"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Deborah Bukola Aremu","raw_affiliation_strings":["Federal University Technology, Minna, Niger State, Nigeria"],"raw_orcid":"https://orcid.org/0009-0006-2292-4329","affiliations":[{"raw_affiliation_string":"Federal University Technology, Minna, Niger State, Nigeria","institution_ids":["https://openalex.org/I76661892"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5116539506","display_name":"Abdillahi Abdi Barkhadle","orcid":"https://orcid.org/0009-0006-7835-7562","observed_orcids":["https://orcid.org/0009-0006-7835-7562"]},"institutions":[{"id":"https://openalex.org/I2801704801","display_name":"Rift Valley University","ror":"https://ror.org/00kga6267","country_code":"ET","type":"education","lineage":["https://openalex.org/I2801704801"]}],"countries":["ET"],"is_corresponding":true,"raw_author_name":"Abdillahi Abdi Barkhadle","raw_affiliation_strings":["Rift Valley University, Jimma, Ethiopia. abdiabdibarkhadle@hotmail.com"],"raw_orcid":"https://orcid.org/0009-0006-7835-7562","affiliations":[{"raw_affiliation_string":"Rift Valley University, Jimma, Ethiopia. abdiabdibarkhadle@hotmail.com","institution_ids":["https://openalex.org/I2801704801"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5116539506"],"corresponding_institution_ids":["https://openalex.org/I2801704801"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5824999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5824999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.4047999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14334","display_name":"HIV/AIDS Impact and Responses","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenacapavir","display_name":"lenacapavir","score":1.0},{"id":"https://openalex.org/keywords/long-acting-hiv-prevention","display_name":"long-acting HIV prevention","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.7900000214576721},{"id":"https://openalex.org/keywords/pre-exposure-prophylaxis","display_name":"pre-exposure prophylaxis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/multidrug-resistant-hiv","display_name":"multidrug-resistant HIV","score":0.7409999966621399},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.6169999837875366},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.7239999771118164},{"id":"https://openalex.org/keywords/health-equity","display_name":"health equity","score":0.8190000057220459},{"id":"https://openalex.org/keywords/pharmaceutical-patents","display_name":"pharmaceutical patents","score":0.4519999921321869},{"id":"https://openalex.org/keywords/licensing-agreements","display_name":"licensing agreements","score":0.8119999766349792},{"id":"https://openalex.org/keywords/sub-saharan-africa","display_name":"sub-Saharan Africa","score":0.7649999856948853},{"id":"https://openalex.org/keywords/health-system-capacity","display_name":"health system capacity","score":0.36899998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.699400007724762},{"id":"https://openalex.org/C70587473","wikidata":"https://www.wikidata.org/wiki/Q7834111","display_name":"Transformative learning","level":2,"score":0.6877999901771545},{"id":"https://openalex.org/C199728807","wikidata":"https://www.wikidata.org/wiki/Q2578557","display_name":"Equity (law)","level":2,"score":0.6315000057220459},{"id":"https://openalex.org/C46578552","wikidata":"https://www.wikidata.org/wiki/Q2725393","display_name":"Global health","level":3,"score":0.5281000137329102},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4650000035762787},{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.450300008058548},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43560001254081726},{"id":"https://openalex.org/C2250968","wikidata":"https://www.wikidata.org/wiki/Q1512929","display_name":"Health equity","level":3,"score":0.4251999855041504},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.3880999982357025},{"id":"https://openalex.org/C2777424817","wikidata":"https://www.wikidata.org/wiki/Q35456","display_name":"Essential medicines","level":3,"score":0.38690000772476196},{"id":"https://openalex.org/C2776889888","wikidata":"https://www.wikidata.org/wiki/Q1135789","display_name":"Unintended consequences","level":2,"score":0.38119998574256897},{"id":"https://openalex.org/C3019492093","wikidata":"https://www.wikidata.org/wiki/Q29468924","display_name":"Access to medicines","level":3,"score":0.37279999256134033},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.36959999799728394},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.353300005197525},{"id":"https://openalex.org/C47344431","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health policy","level":3,"score":0.3319999873638153},{"id":"https://openalex.org/C168285401","wikidata":"https://www.wikidata.org/wiki/Q1427245","display_name":"Stigma (botany)","level":2,"score":0.3203999996185303},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3093000054359436},{"id":"https://openalex.org/C47768531","wikidata":"https://www.wikidata.org/wiki/Q1127188","display_name":"Development economics","level":1,"score":0.3089999854564667},{"id":"https://openalex.org/C199033989","wikidata":"https://www.wikidata.org/wiki/Q1318295","display_name":"Narrative","level":2,"score":0.30169999599456787},{"id":"https://openalex.org/C513891491","wikidata":"https://www.wikidata.org/wiki/Q181865","display_name":"Civil society","level":3,"score":0.2978000044822693},{"id":"https://openalex.org/C124056412","wikidata":"https://www.wikidata.org/wiki/Q3320364","display_name":"Scientific evidence","level":2,"score":0.2946000099182129},{"id":"https://openalex.org/C2779872411","wikidata":"https://www.wikidata.org/wiki/Q1774161","display_name":"International community","level":3,"score":0.2896000146865845},{"id":"https://openalex.org/C99527880","wikidata":"https://www.wikidata.org/wiki/Q781118","display_name":"Universal design","level":2,"score":0.2865000069141388},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.28519999980926514},{"id":"https://openalex.org/C184356942","wikidata":"https://www.wikidata.org/wiki/Q830382","display_name":"Best practice","level":2,"score":0.2824999988079071},{"id":"https://openalex.org/C43540301","wikidata":"https://www.wikidata.org/wiki/Q689971","display_name":"Paradigm shift","level":2,"score":0.2782000005245209},{"id":"https://openalex.org/C83864248","wikidata":"https://www.wikidata.org/wiki/Q177323","display_name":"Developing country","level":2,"score":0.2745000123977661},{"id":"https://openalex.org/C45555294","wikidata":"https://www.wikidata.org/wiki/Q28113351","display_name":"Inequality","level":2,"score":0.2623000144958496},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.2605000138282776},{"id":"https://openalex.org/C2779622097","wikidata":"https://www.wikidata.org/wiki/Q1417724","display_name":"Capacity building","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2563999891281128},{"id":"https://openalex.org/C105152847","wikidata":"https://www.wikidata.org/wiki/Q5021685","display_name":"Call to action","level":2,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/s12981-026-00921-1","doi":"https://doi.org/10.1186/s12981-026-00921-1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-026-00921-1","pdf_url":null,"source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},{"id":"pmid:42410439","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42410439","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/s12981-026-00921-1","doi":"https://doi.org/10.1186/s12981-026-00921-1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-026-00921-1","pdf_url":null,"source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/10","score":0.7578999996185303,"display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204176108","https://openalex.org/W7147292723","https://openalex.org/W7128594099","https://openalex.org/W4403388201","https://openalex.org/W7221808312","https://openalex.org/W4412733780","https://openalex.org/W4416111179","https://openalex.org/W4411183705","https://openalex.org/W7133696068","https://openalex.org/W7161600038"],"abstract_inverted_index":{"Lenacapavir":[0,218],"is":[1,98],"a":[2,8,28,63,120,126,220],"first-in-class":[3],"HIV":[4,32,40,76,173,213,224],"capsid":[5],"inhibitor":[6],"with":[7,107,135],"long-acting":[9,112],"formulation":[10],"that":[11,96],"enables":[12],"twice-yearly":[13,123],"dosing":[14,25],"for":[15],"both":[16],"treatment":[17,77,216],"and":[18,23,55,66,78,80,84,110,141,147,170,181,202,209,215,226,246],"prevention.":[19,227],"Its":[20,228],"novel":[21],"mechanism":[22],"extended":[24],"interval":[26],"represent":[27],"paradigm":[29],"shift":[30],"in":[31,75,90,101,185,223,230],"care.":[33],"Sub-Saharan":[34],"Africa":[35,156,231],"bears":[36],"the":[37,81,136],"highest":[38],"global":[39,57,172],"burden":[41],"but":[42,239],"has":[43],"historically":[44],"experienced":[45],"delayed":[46],"access":[47,89,154,190],"to":[48,129,138,145,205],"biomedical":[49],"innovations,":[50],"raising":[51],"concerns":[52],"about":[53],"equity":[54],"persistent":[56],"health":[58],"disparities.":[59],"This":[60],"article":[61],"presents":[62],"narrative":[64],"review":[65],"policy":[67,85],"analysis":[68],"examining":[69],"lenacapavir's":[70],"scientific":[71,237],"potential,":[72],"its":[73,111,151],"role":[74],"prevention,":[79],"structural,":[82],"economic,":[83],"challenges":[86,176],"affecting":[87],"equitable":[88,153,189],"African":[91],"settings.":[92,187],"Emerging":[93],"evidence":[94],"indicates":[95],"lenacapavir":[97],"highly":[99],"effective":[100],"heavily":[102],"treatment-experienced":[103],"individuals,":[104],"including":[105],"those":[106],"multidrug-resistant":[108],"HIV,":[109],"pharmacokinetic":[113],"profile":[114],"supports":[115],"sustained":[116],"viral":[117],"suppression.":[118],"As":[119],"prevention":[121,214],"strategy,":[122],"administration":[124],"offers":[125],"practical":[127],"alternative":[128],"daily":[130],"oral":[131],"pre-exposure":[132],"prophylaxis":[133],"(PrEP),":[134],"potential":[137],"improve":[139],"adherence":[140],"overcome":[142],"barriers":[143],"related":[144],"stigma":[146],"pill":[148],"burden.":[149],"Despite":[150],"promise,":[152],"across":[155],"may":[157],"be":[158],"limited":[159],"by":[160],"high":[161],"costs,":[162],"patent":[163],"protections,":[164],"restricted":[165],"licensing":[166],"agreements,":[167],"health-system":[168],"weaknesses,":[169],"evolving":[171],"financing.":[174],"These":[175],"could":[177],"hinder":[178],"timely":[179],"introduction":[180],"widespread":[182],"uptake,":[183],"particularly":[184],"resource-constrained":[186],"Ensuring":[188],"will":[191,232],"require":[192],"coordinated":[193,247],"action":[194],"among":[195],"governments,":[196],"international":[197],"agencies,":[198],"pharmaceutical":[199],"manufacturers,":[200],"donors,":[201],"civil":[203],"society":[204],"strengthen":[206],"affordability,":[207],"availability,":[208],"implementation":[210,248],"within":[211],"existing":[212],"programs.":[217],"represents":[219],"transformative":[221],"advance":[222],"therapy":[225],"impact":[229],"depend":[233],"not":[234],"only":[235],"on":[236,241],"innovation":[238],"also":[240],"equity-focused":[242],"policies,":[243],"sustainable":[244],"financing,":[245],"strategies.":[249]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-07-07T00:00:00"}